These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19403648)

  • 21. PPARgamma agonists do not directly enhance basal or insulin-stimulated Na(+) transport via the epithelial Na(+) channel.
    Nofziger C; Chen L; Shane MA; Smith CD; Brown KK; Blazer-Yost BL
    Pflugers Arch; 2005 Dec; 451(3):445-53. PubMed ID: 16170524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxisome proliferator-activated receptor gamma-mediated NF-kappa B activation and apoptosis in pre-B cells.
    Schlezinger JJ; Jensen BA; Mann KK; Ryu HY; Sherr DH
    J Immunol; 2002 Dec; 169(12):6831-41. PubMed ID: 12471115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Butyrate increases apical membrane CFTR but reduces chloride secretion in MDCK cells.
    Moyer BD; Loffing-Cueni D; Loffing J; Reynolds D; Stanton BA
    Am J Physiol; 1999 Aug; 277(2):F271-6. PubMed ID: 10444582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel partial agonist of peroxisome proliferator-activated receptor-gamma (PPARgamma) recruits PPARgamma-coactivator-1alpha, prevents triglyceride accumulation, and potentiates insulin signaling in vitro.
    Burgermeister E; Schnoebelen A; Flament A; Benz J; Stihle M; Gsell B; Rufer A; Ruf A; Kuhn B; Märki HP; Mizrahi J; Sebokova E; Niesor E; Meyer M
    Mol Endocrinol; 2006 Apr; 20(4):809-30. PubMed ID: 16373399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The nonthiazolidinedione tyrosine-based peroxisome proliferator-activated receptor gamma ligand GW7845 induces apoptosis and limits migration and invasion of rat and human glioma cells.
    Grommes C; Landreth GE; Schlegel U; Heneka MT
    J Pharmacol Exp Ther; 2005 May; 313(2):806-13. PubMed ID: 15665144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PPARγ as a therapeutic target in cystic fibrosis.
    Dekkers JF; van der Ent CK; Kalkhoven E; Beekman JM
    Trends Mol Med; 2012 May; 18(5):283-91. PubMed ID: 22494945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effects of PPARγ agonist in acute nephrotic syndrome.
    Zuo Y; Yang HC; Potthoff SA; Najafian B; Kon V; Ma LJ; Fogo AB
    Nephrol Dial Transplant; 2012 Jan; 27(1):174-81. PubMed ID: 21565943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the EGF receptor in PPARγ-mediated sodium and water transport in human proximal tubule cells.
    Saad S; Zhang J; Yong R; Yaghobian D; Wong MG; Kelly DJ; Chen XM; Pollock CA
    Diabetologia; 2013 May; 56(5):1174-82. PubMed ID: 23370527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A yeast two-hybrid technology-based system for the discovery of PPARgamma agonist and antagonist.
    Chen Q; Chen J; Sun T; Shen J; Shen X; Jiang H
    Anal Biochem; 2004 Dec; 335(2):253-9. PubMed ID: 15556564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulation of ENaC activity by rosiglitazone is PPARγ-dependent and correlates with SGK1 expression increase.
    Renauld S; Tremblay K; Ait-Benichou S; Simoneau-Roy M; Garneau H; Staub O; Chraïbi A
    J Membr Biol; 2010 Aug; 236(3):259-70. PubMed ID: 20740360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α.
    Takano M; Otsuka F; Matsumoto Y; Inagaki K; Takeda M; Nakamura E; Tsukamoto N; Miyoshi T; Sada KE; Makino H
    Mol Cell Endocrinol; 2012 Jan; 348(1):224-32. PubMed ID: 21888945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved insulin sensitivity after treatment with PPARγ and PPARα ligands is mediated by genetically modulated transcripts.
    Rasouli N; Kern PA; Elbein SC; Sharma NK; Das SK
    Pharmacogenet Genomics; 2012 Jul; 22(7):484-97. PubMed ID: 22437669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypercapnia modulates cAMP signalling and cystic fibrosis transmembrane conductance regulator-dependent anion and fluid secretion in airway epithelia.
    Turner MJ; Saint-Criq V; Patel W; Ibrahim SH; Verdon B; Ward C; Garnett JP; Tarran R; Cann MJ; Gray MA
    J Physiol; 2016 Mar; 594(6):1643-61. PubMed ID: 26574187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of ambroxol on chloride transport, CFTR and ENaC in cystic fibrosis airway epithelial cells.
    Varelogianni G; Hussain R; Strid H; Oliynyk I; Roomans GM; Johannesson M
    Cell Biol Int; 2013 Nov; 37(11):1149-56. PubMed ID: 23765701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. G Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor γ (PPARγ): AN INTEGRATED TWO-RECEPTOR SIGNALING PATHWAY.
    Wang S; Awad KS; Elinoff JM; Dougherty EJ; Ferreyra GA; Wang JY; Cai R; Sun J; Ptasinska A; Danner RL
    J Biol Chem; 2015 Aug; 290(32):19544-57. PubMed ID: 26105050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peroxisome Proliferator-activated receptor γ activation by ligands and dephosphorylation induces proprotein convertase subtilisin kexin type 9 and low density lipoprotein receptor expression.
    Duan Y; Chen Y; Hu W; Li X; Yang X; Zhou X; Yin Z; Kong D; Yao Z; Hajjar DP; Liu L; Liu Q; Han J
    J Biol Chem; 2012 Jul; 287(28):23667-77. PubMed ID: 22593575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TGFbeta down-regulation of the CFTR: a means to limit epithelial chloride secretion.
    Howe KL; Wang A; Hunter MM; Stanton BA; McKay DM
    Exp Cell Res; 2004 Aug; 298(2):473-84. PubMed ID: 15265695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model.
    Nakano Y; Arima T; Tobita Y; Uchiyama M; Shimizu A; Takahashi H
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32707656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peroxisome proliferated-activated receptor gamma ligand, Pioglitazone, does not prevent hepatic fibrosis in mice.
    Da Silva Morais A; Abarca-Quinones J; Horsmans Y; Stärkel P; Leclercq IA
    Int J Mol Med; 2007 Jan; 19(1):105-12. PubMed ID: 17143554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PPARγ agonist pioglitazone inhibits microglia inflammation by blocking p38 mitogen-activated protein kinase signaling pathways.
    Ji H; Wang H; Zhang F; Li X; Xiang L; Aiguo S
    Inflamm Res; 2010 Nov; 59(11):921-9. PubMed ID: 20495845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.